Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
- pharma
Bacillus calmette-guerin live antigen, unspecified substrain
Concern score
Not assessed — no hazard data yet.
Bacillus calmette-guerin live antigen, unspecified substrain in plain language
Also known as Bcg vaccine · Bacillus calmette-guerin vaccine · Bacillus calmette-guerin antigen · Unspecified substrain bacillus calmette-guerin antigen
Show all 7 names
Bcg · Live bcg vaccine · Unspecified substrain bcg vaccine
We don't have a plain-language description for Bacillus calmette-guerin live antigen, unspecified substrain yet.
- We haven't assessed a concern score for this ingredient yet.
Regulation
No restrictions found. Bacillus calmette-guerin live antigen, unspecified substrain appears in these published regulatory listings.
- In marketed US drugs
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 3 active drug products and 3 total products.
- FDA NDC lists this ingredient in 3 active drug products and 3 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as mixture.
- openFDA substance registry classifies this ingredient as mixture.Source →
Evidence & sources
No graded research studies for Bacillus calmette-guerin live antigen, unspecified substrain yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
No signal in this context
Where it has been recorded
How often FDA National Drug Code directory has listed Bacillus calmette-guerin live antigen, unspecified substrain in a product composition. These are source records, not Greenveil catalog products.
Source records
3